Decitabine Injection, Powder, Lyophilized, For Solution
Product Images NDC 0143-9385

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Decitabine (NDC 0143-9385). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Decitabine For Injection 1)

Chemical structure of decitabine, showing its molecular arrangement with a cytosine nucleoside base linked to a sugar ring.*

FDA Label Image

80964b02 (Decitabine For Injection 2)

Label for Decitabine for Injection 50 mg per vial, lyophilized powder for intravenous infusion. The label indicates it is a single dose sterile vial and a cytotoxic agent. Manufactured by Jiangsu Hansoh Pharmaceutical Group, Ltd. and distributed by Hikma Pharmaceuticals USA Inc.*

FDA Label Image

80965b02 Again (Decitabine For Injection 3)

Decitabine for Injection 50 mg per vial label for intravenous infusion only. The label states it is a single dose sterile vial with a warning indicating it is a cytotoxic agent. It includes storage instructions at 20°C to 25°C and mentions aseptic reconstitution with sterile water to yield a 5 mg/mL solution. Manufactured by Jiangsu Hanhua Pharmaceutical Group and distributed by Hikma Pharmaceuticals USA Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.